Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 12, pp. 834-851
Closed Access | Times Cited: 20

Showing 20 citing articles:

Liver Cancer in 2021: Global Burden of Disease Study
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 17
Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection
Nobuharu Tamaki, Masayuki Kurosaki
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease
Tung‐Hung Su, Sheng‐Shun Yang, Mei–Hsuan Lee, et al.
Clinical and Molecular Hepatology (2025)
Open Access
Recent advances in self-targeting natural product-based nanomedicines
Haifan Liu, Xingyue Jin, Suyi Liu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Encoding the Intra- and Peri-Tumoral Heterogeneity of Hepatocellular Carcinoma for Micro-Vascular Invasion Prediction and Prognostic Risk Stratification: A Multicenter Study
Yunfei Zhang, Shutong Wang, Mingyue Song, et al.
(2025)
Closed Access
A novel nomogram based on complement C3 to predict the overall survival of early-stage hepatocellular carcinoma patients with microvascular invasion-positive undergoing curative resection
Guoyi Xia, Ze‐Yan Yu, Shaolong Lu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Neoadjuvant therapy: Dawn of reducing the high post-surgery recurrence rate of hepatocellular carcinoma
Xiaodong Zhang, Luyi Zhang, Jialiang Luo, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 3
Closed Access
Histidine metabolism drives liver cancer progression via immune microenvironment modulation through metabolic reprogramming
Pengcheng Liu, Fuxin Huang, Peixu Lin, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Exosomes: A Promising Drug Delivery Tool in Hepatic Drug Delivery
Neha Kanojia, Komal Thapa, Thakur Gurjeet Singh, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106761-106761
Closed Access
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai‐Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access
CGREF1 facilitates the cell proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of EIF3H/ Wnt/β-Catenin signaling axis
Dongkai Gao, Zumo Zhou, Lin Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Research progress on AMPK in the pathogenesis and treatment of MASLD
Jiang Feng, Menghuan Li, Tingting Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Underrepresentation of Asians in diagnostic test development and drug trials in MASLD
Lung‐Yi Mak, Terry Cheuk‐Fung Yip, Chi‐Ho Lee, et al.
Journal of Hepatology (2025)
Closed Access
Comparison of NAFLD, MAFLD And MASLD Prevalence And Clinical Characteristics in Asia Adults
Xinjuan Huang, Ruoling Yu, Xinyun Tan, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 1, pp. 102420-102420
Closed Access | Times Cited: 4
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 3
Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and Challenges
Alessandro Rizzo, Oronzo Brunetti, Giovanni Brandi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11091-11091
Open Access | Times Cited: 2
MicroRNA-107 – a small RNA with a big impact on cytokinesis in hepatocellular carcinoma
Xiaowei Zhong, Michael Ott, Amar Deep Sharma, et al.
Journal of Hepatology (2024)
Closed Access
Protein induced by vitamin K absence-II for the surveillance and monitoring of hepatocellular carcinoma in Hong Kong
Rashid N. Lui, Loey LY Mak, KN Kung, et al.
Hong Kong Medical Journal (2024)
Open Access
Surveillance for hepatocellular carcinoma in cirrhosis: End of monopoly for serum alpha fetoprotein
Lung‐Yi Mak, Man‐Fung Yuen
Gastroenterology (2024)
Closed Access
Transforming the landscape of liver cancer detection and care
Terry Cheuk‐Fung Yip, Grace Lai‐Hung Wong
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access
Page 1

Scroll to top